Analysis of myelodysplastic syndrome clones arising after multiple myeloma: A case study by correlative interphase cytogenetic analysis

Japanese Journal of Clinical Oncology

Volumn 29, Issue 8, 1999, Pages 374-377

  Kobayashi, Yukio ^a,b,c   Nakayama, Michihiro ^a   Uemura, Naoki ^a   Takeyama, Kunihiko ^b   Tobinai, Kensei ^b   Takenaka, Takeaki ^b   Choi, Soon Hee ^a   Satoh, Hitoshi ^a   Mori, Shigeo ^a   Asano, Shigetaka ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c NATIONAL CANCER CENTER   (Japan)

Author keywords

Chromosome analysis; FISH; MDS; Multiple myeloma

Indexed keywords

ARTICLE; CASE REPORT; CELL CLONE; CHROMOSOME 9; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; INTERPHASE; MIDDLE AGED; MONOSOMY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; PATHOLOGY;

CHROMOSOMES, HUMAN, PAIR 9; CLONE CELLS; CYTOGENETICS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; MIDDLE AGED; MONOSOMY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROMES;

EID: 0033173509     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.8.374     Document Type: Article

References (21)

1. Epstein J, Xiao H, He X-Y. Markers of multiple hematopoietic-cell lineages in multiple myeloma. N Engl J Med 1990;322:664-8.
2. Jensen GS, Mant MJ, Belch AJ, Berenson JR, Ruether BA, Pilarski LM. Selective expression of CD 45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood 1991;78:711-9.
3. King MA, Nelson DS. Tumour tell heterogeneity in multiple myeloma: antigenic morphologic and functional studies of cells from blood and bone marrow. Blood 1989;73:1925-5.
4. Grogan TM, Durie BGM, Spier CM, Richter L, Vela E. Myelomonocytic antigen positive multiple myeloma. Blood 1989;73:763-9.
5. Rosner F, Grünwald HW. Simultaneous occurrence of multiple myeloma and acute myeloblastic leukemia: Fact or myth? Am J Med 1984;76:891-9.
6. Coltman CA Jr.Treatment related leukemia. In: Bloomfield CD, editor. Adult Leukemia 1. The Hague: Martinus Nijhoff 1982;61-108.
7. Nakayama M, Kobayashi Y, Oshima Y, Uemura N, Shindo E, Tajika K, et al. Multiple myeloma developing myelodysplastic syndrome with thorombocytosis. Rinsho Ketsueki 1995;36:703-6 (in Japanese).
8. Pedersen-Bjergaard J, Rowley JD. The balanced and the unbalanced aberrations of acute myeloid leukemia may develop in different ways and may be contribute differently to malignant transformation. Blood 1994;83:2780-6.
9. Escudier SM, Pereira-Leahy JM, Drach JW, Weier HU, Goodacre AM, Cork MA, et al. Ruorescence in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia. Blood 1993;81:2702-7.
10. Que TH, Marco JG, Ellis J, Matutes E, Brito Babapulle V, Boyle S, et al. Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype and morphology. Blood 1993;82:571-5.
11. Anastasi J, Vardiman JW, Rudinsky R, Patel M, Nachman J, Rubin CM, et al. Direct correlation of cytogenetic findings with cell morphology using in situ hybridization: an analysis of suspicious cells in bone marrow specimens of two patients completing therapy for acute lymphoblastic leukemia. Blood 1991;77:2456-62.
12. Anastasi J, Feng J, Le Beau MM, Rarson RA, Rowley JD, Vardiman JW. Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy and clone expansion. Blood 1993;81:1580-5.
13. Bentz M, Schröder M, Herz M, Stilgenbauer S, Lichter P, Döhner H. Detection of trisomy 8 on blood smears using fluorescence in situ hybridization. Leukemia 1993;7:752-7.
14. Pederson-Bjergaard J, Pederson M, Roulston D, Philip P. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood 1995;86:3542-52.
15. Prchal JT, Throckmorton DW, Carroll AJ III, Fuson EW, Gams RA, Prchal JF. A common progenitor for human myeloid and lymphoid cells. Nature 1978;274:590-1.
16. Janssen JWG, Buschile M, Layton M, Drexler NG, Lyons J, Van der Berghe H, et al. Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood 1989;73:248-54.
17. Epstein J, Barlogie B, Katzmann J, Alexanian R. Phenotypic heterogeneity in aneuploid multiple myeloma. Blood 1988;71:861.
18. Barlogie B, Epstein J, Salvanayagam P, Alexanian R. Plasma cell myeloma - New biological insights and advances in therapy. Blood 1989;73:865-79.
19. Dao DD, Sawyer JR, Epstein J, Hoover RG, Barlogie B, Tricot G. Deletion of the retinoblastoma gene in multiple myeloma. Leukemia 1994;8:1280-4.
20. Drach J, Schuster J, Nowotny H, Angerler J, Rosenthal F, Fiegl M, et al. Multiple myeloma: high incidence of chromosomal aneuploidity by interphase fluorescence in situ hybridization. Cancer Res 1995;55:3854-9.
21. Selig S, Okumura K, Ward DC, Cedar H. Delineation of DNA replication timezones by fluorescence in situ hybridization. EMBO J 1992;11:1217-25.